Tue, Aug 20 10:48am

Compare ALXN



Alexion Pharmaceuticals Inc [ALXN]
$113.26 0.58 (0.51%)

ALXN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 24.86 Billion
ALXN Description

Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and generalized myasthenia gravis. Next-generation Ultomiris was recently approved in paroxysmal nocturnal hemoglobinuria. Strensiq and Kanuma target other ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need and complement-mediated disorders.


Visit Website

ALXN Earnings

EPS 2.05 P/E Ratio 392.83
Previous Earnings Thu, Apr 25, 2019
Latest Earnings Wed, Jul 24, 2019 (27 days ago) -7.95%

ALXN Dividend

Yield --
Ex-Date --
Pay Date --
History --

ALXN Charts

$92.56
1 Year
$141.86
Dec 24, 2018
Apr 10, 2019



Symbol Price Day % YTD %
ALXN $113.26 0.51% 15.51%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy